Bizengri (Zenocutuzumab): Uses, Side Effects & Interactions
Bizengri (zenocutuzumab) is a bispecific antibody targeting HER2 and HER3, indicated for the treatment of adult patients with advanced, unresectable, or metastatic solid tumors harboring an NRG1 gene fusion. The most notable side effect involves infusion-related reactions and severe diarrhea, while serious clinical risks include profound interstitial lung disease and significant left ventricular dysfunction. 1. … Read more